After adjusting for age at diagnosis, primary tumor status, lymph node status and tumor differentiation using multivariate analysis, patients with high FADD protein expression also showed a poorer DFS (HR = 1.575, 95% CI, 1.078–2.300) (S4 Table). This evidence concerns the gene FADD and neoplasm.